Insignificant disease among men with intermediate-risk prostate cancer

被引：0
|
作者：
Sung Kyu Hong
Emily Vertosick
Daniel D. Sjoberg
Peter T. Scardino
James A. Eastham
机构：
[1] Memorial Sloan-Kettering Cancer Center,Urology Service, Department of Surgery
[2] Seoul National University Bundang Hospital,Department of Urology
[3] Memorial Sloan-Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] Cornell University,Department of Urology, Weill Cornell Medical College
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate; Prostatic neoplasms; Insignificant; Intermediate risk; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1417 / 1421
页数：4
相关论文
共 50 条
  • [41] Radiation treatment for patients with intermediate-risk prostate cancer
    Greene, David E.
    Mayadev, Jyoti S.
    Valicenti, Richard K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (03) : 113 - 124
  • [42] BURDEN OF DEPRESSION AND ANXIETY IN MEN WITH HIGH-RISK, INTERMEDIATE-RISK OR LOW-RISK PROSTATE CANCER
    Chhatre, Sumedha
    Malkowicz, S. Bruce
    Jayadevappa, Ravishankar
    JOURNAL OF UROLOGY, 2022, 207 (05): : E463 - E463
  • [43] Reoxygenation during radiotherapy in intermediate-risk prostate cancer
    Supiot, Stephane
    Rousseau, Caroline
    Dore, Melanie
    Cheze-Le-Rest, Catherine
    Kandel-Aznar, Christine
    Potiron, Vincent
    Guerif, Stephane
    Paris, Francois
    Ferrer, Ludovic
    Campion, Loic
    Meingan, Philippe
    Delpon, Gregory
    Hatt, Mathieu
    Visvikis, Dimitris
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 16 - 19
  • [44] Survival outcomes for young men with localized intermediate-risk prostate cancer: An analysis of the NCDB.
    Boyd, Graham
    Qureshi, Muhammad M.
    Gignac, Gretchen
    Hirsch, Ariel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials
    Powell, IJ
    Meyskens, FL
    UROLOGY, 2001, 57 (4A) : 178 - 181
  • [46] Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer
    Moschini, Marco
    Gandaglia, Giorgio
    Suardi, Nazareno
    Fossati, Nicola
    Cucchiara, Vito
    Damiano, Rocco
    Cantiello, Francesco
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Briganti, Alberto
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 555 - 561
  • [47] Prevalence and Predictors of Active Surveillance Utilization Among Hispanic, Black, and White Men Diagnosed With Favorable Intermediate-Risk Prostate Cancer
    Taku, N.
    Narayan, V.
    Bellamy, S.
    Vapiwala, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E417 - E417
  • [48] INTERMEDIATE-RISK PROSTATE CANCER, ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEATH
    Pickles, Tom
    Tyldesley, Scott
    Keyes, Mira
    Morris, W. James
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S27 - S27
  • [49] Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death
    Pickles, Tom
    Tyldesley, Scott
    Hamm, Jeremy
    Virani, Sean A.
    Morris, W. James
    Keyes, Mira
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 45 - 52
  • [50] No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
    Cyll, Karolina
    Loffeler, Sven
    Carlsen, Birgitte
    Skogstad, Karin
    Plathan, May Lisbeth
    Landquist, Martin
    Haug, Erik Skaaheim
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345